Back to search

France· FR:63737879

DEPAMIDE 300 mg, comprimé pelliculé gastro-résistant

A valpromide product containing valpromide, registered in France by SANOFI WINTHROP INDUSTRIE, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC N03AG02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedDEPAMIDE 300 mg, comprimé pelliculé g…ATCN03AG02REGISTER NO.FR:63737879PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Valpromide is registered in 2 of 19 countries.

Countries holding a registration under ATC N03AG02 (valpromide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 2 of them publish a price we can compare per daily dose

Valpromide · ATC N03AG02

2 / 19 countries

  • Franceprice
  • Italyprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valpromide costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

  • France: $0.79 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Valpromide · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • IT Italy$0.93
  • FR France$0.79
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
VALPROMIDE
Manufacturer
SANOFI WINTHROP INDUSTRIE
Country
France (FR)
ATC code
N03AG02
ATC class
Valpromide
Defined daily dose
1.5 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

1 priced
  • cip13
    3400932070619
    plaquette(s) thermoformée(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)
    EUR 4.14
  • cip13
    3400955900061
    plaquette(s) thermoformée(s) polyamide aluminium PVC-Aluminium de 50 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Valpromide in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valpromide products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Italy · Depamide

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/241306fe-2508-4916-9919-758135d64fdc
GET /v1/drugs/241306fe-2508-4916-9919-758135d64fdc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63737879",
  "date_amm": "1977-01-10",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "VALPROMIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé gastro-résistant(e)",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about valpromide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.